![]() 経皮鎮痛薬-世界市場シェアとランキング、全体売上高と需要予測 2025-2031Transdermal Analgesics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031 経皮鎮痛薬の世界市場は、2024年には100万米ドル規模になると推定され、2031年には100万米ドルに再調整され、予測期間2025-2031年の年平均成長率は%になると予測されている。 経皮吸収型鎮痛薬の北米市場は、2... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリー経皮鎮痛薬の世界市場は、2024年には100万米ドル規模になると推定され、2031年には100万米ドルに再調整され、予測期間2025-2031年の年平均成長率は%になると予測されている。経皮吸収型鎮痛薬の北米市場は、2024年に100万米ドル規模となり、2025年から2031年の予測期間中に年平均成長率%で、2031年には100万米ドルに達すると予測されています。 経皮鎮痛薬のアジア太平洋市場は、2024年に100万ドルと評価され、2025年から2031年の予測期間中に%のCAGRで、2031年までに100万ドルに達するだろう。 経皮鎮痛薬のヨーロッパ市場は、2024年に100万ドルと評価され、2025年から2031年の予測期間中に%のCAGRで、2031年までに100万ドルに達するでしょう。 経皮鎮痛薬の世界的な主要企業には、アボット・ラボラトリーズ、アッヴィ社、バイエル社、イーライリリー・アンド・カンパニー、エンド・ファーマシューティカルズ、グラクソスミスクライン社、ジョンソン・アンド・ジョンソンmd&d社、ファイザー社、レキットベンキーザー・グループ、サノフィ社などがあります。2024年には、世界の大手5社が売上高で約 %のシェアを占めています。 本レポートは、経皮吸収型鎮痛薬の世界市場を包括的に紹介することを目的としており、地域別・国別、タイプ別、用途別の経皮吸収型鎮痛薬の分析とともに、総販売量、販売収益、価格、主要企業の市場シェアとランキングに焦点を当てています。 経皮吸収型鎮痛薬の市場規模、推計、予測は、2024年を基準年として、2020年から2031年までの期間の履歴データと予測データとともに、販売数量(K単位)と販売収益(百万ドル)で提供されます。量的および質的分析により、読者がビジネス/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、経皮鎮痛薬に関する情報に基づいたビジネス上の意思決定を行うのに役立ちます。 市場区分 企業別 アボット・ラボラトリーズ アッヴィ社 バイエル イーライリリー・アンド・カンパニー グラクソスミスクライン plc ジョンソン・アンド・ジョンソン MD&D ファイザー レキットベンキーザーグループ サノフィ タイプ別セグメント 非オピオイド オピオイド 用途別セグメント 病院 薬局 ファミリー 地域別 北米 アメリカ カナダ アジア太平洋 中国 日本 韓国 東南アジア インド オーストラリア その他のアジア太平洋地域 ヨーロッパ ドイツ フランス 英国 イタリア オランダ 北欧諸国 その他のヨーロッパ ラテンアメリカ メキシコ ブラジル その他のラテンアメリカ 中東・アフリカ トルコ サウジアラビア アラブ首長国連邦 その他のMEA 各章の概要 第1章: レポートの対象範囲、世界の総市場規模(金額、数量、価格)を紹介します。本章ではまた、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界メーカーが直面する課題とリスク、業界の関連政策の分析を提供します。 第2章:経皮吸収型鎮痛薬メーカーの競争環境、価格、売上高、市場シェア、最新の開発計画、合併・買収情報などを詳細に分析。 第3章:タイプ別に様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展可能性をカバーし、読者が異なる市場セグメントでブルーオーシャン市場を見つけるのを助ける。 第4章:アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展可能性をカバーし、読者が異なる川下市場のブルーオーシャン市場を見つけるのに役立ちます。 第5章:経皮鎮痛薬の地域別売上高、収益。各地域の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、将来発展見込み、市場空間、市場規模を紹介しています。 第6章:経皮吸収型鎮痛薬の国別売上高、収益。各国・地域のタイプ別、用途別のシグメイトデータを提供。 第7章:主要企業のプロファイルを提供し、製品の売上高、収益、価格、粗利益率、製品紹介、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介します。 第8章:産業の上流と下流を含む産業チェーンの分析。 第9章:結論 目次1 Market Overview1.1 Transdermal Analgesics Product Introduction 1.2 Global Transdermal Analgesics Market Size Forecast 1.2.1 Global Transdermal Analgesics Sales Value (2020-2031) 1.2.2 Global Transdermal Analgesics Sales Volume (2020-2031) 1.2.3 Global Transdermal Analgesics Sales Price (2020-2031) 1.3 Transdermal Analgesics Market Trends & Drivers 1.3.1 Transdermal Analgesics Industry Trends 1.3.2 Transdermal Analgesics Market Drivers & Opportunity 1.3.3 Transdermal Analgesics Market Challenges 1.3.4 Transdermal Analgesics Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Transdermal Analgesics Players Revenue Ranking (2024) 2.2 Global Transdermal Analgesics Revenue by Company (2020-2025) 2.3 Global Transdermal Analgesics Players Sales Volume Ranking (2024) 2.4 Global Transdermal Analgesics Sales Volume by Company Players (2020-2025) 2.5 Global Transdermal Analgesics Average Price by Company (2020-2025) 2.6 Key Manufacturers Transdermal Analgesics Manufacturing Base and Headquarters 2.7 Key Manufacturers Transdermal Analgesics Product Offered 2.8 Key Manufacturers Time to Begin Mass Production of Transdermal Analgesics 2.9 Transdermal Analgesics Market Competitive Analysis 2.9.1 Transdermal Analgesics Market Concentration Rate (2020-2025) 2.9.2 Global 5 and 10 Largest Manufacturers by Transdermal Analgesics Revenue in 2024 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Analgesics as of 2024) 2.10 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Non opioids 3.1.2 Opioids 3.2 Global Transdermal Analgesics Sales Value by Type 3.2.1 Global Transdermal Analgesics Sales Value by Type (2020 VS 2024 VS 2031) 3.2.2 Global Transdermal Analgesics Sales Value, by Type (2020-2031) 3.2.3 Global Transdermal Analgesics Sales Value, by Type (%) (2020-2031) 3.3 Global Transdermal Analgesics Sales Volume by Type 3.3.1 Global Transdermal Analgesics Sales Volume by Type (2020 VS 2024 VS 2031) 3.3.2 Global Transdermal Analgesics Sales Volume, by Type (2020-2031) 3.3.3 Global Transdermal Analgesics Sales Volume, by Type (%) (2020-2031) 3.4 Global Transdermal Analgesics Average Price by Type (2020-2031) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Hospital 4.1.2 Pharmacy 4.1.3 Family 4.2 Global Transdermal Analgesics Sales Value by Application 4.2.1 Global Transdermal Analgesics Sales Value by Application (2020 VS 2024 VS 2031) 4.2.2 Global Transdermal Analgesics Sales Value, by Application (2020-2031) 4.2.3 Global Transdermal Analgesics Sales Value, by Application (%) (2020-2031) 4.3 Global Transdermal Analgesics Sales Volume by Application 4.3.1 Global Transdermal Analgesics Sales Volume by Application (2020 VS 2024 VS 2031) 4.3.2 Global Transdermal Analgesics Sales Volume, by Application (2020-2031) 4.3.3 Global Transdermal Analgesics Sales Volume, by Application (%) (2020-2031) 4.4 Global Transdermal Analgesics Average Price by Application (2020-2031) 5 Segmentation by Region 5.1 Global Transdermal Analgesics Sales Value by Region 5.1.1 Global Transdermal Analgesics Sales Value by Region: 2020 VS 2024 VS 2031 5.1.2 Global Transdermal Analgesics Sales Value by Region (2020-2025) 5.1.3 Global Transdermal Analgesics Sales Value by Region (2026-2031) 5.1.4 Global Transdermal Analgesics Sales Value by Region (%), (2020-2031) 5.2 Global Transdermal Analgesics Sales Volume by Region 5.2.1 Global Transdermal Analgesics Sales Volume by Region: 2020 VS 2024 VS 2031 5.2.2 Global Transdermal Analgesics Sales Volume by Region (2020-2025) 5.2.3 Global Transdermal Analgesics Sales Volume by Region (2026-2031) 5.2.4 Global Transdermal Analgesics Sales Volume by Region (%), (2020-2031) 5.3 Global Transdermal Analgesics Average Price by Region (2020-2031) 5.4 North America 5.4.1 North America Transdermal Analgesics Sales Value, 2020-2031 5.4.2 North America Transdermal Analgesics Sales Value by Country (%), 2024 VS 2031 5.5 Europe 5.5.1 Europe Transdermal Analgesics Sales Value, 2020-2031 5.5.2 Europe Transdermal Analgesics Sales Value by Country (%), 2024 VS 2031 5.6 Asia Pacific 5.6.1 Asia Pacific Transdermal Analgesics Sales Value, 2020-2031 5.6.2 Asia Pacific Transdermal Analgesics Sales Value by Region (%), 2024 VS 2031 5.7 South America 5.7.1 South America Transdermal Analgesics Sales Value, 2020-2031 5.7.2 South America Transdermal Analgesics Sales Value by Country (%), 2024 VS 2031 5.8 Middle East & Africa 5.8.1 Middle East & Africa Transdermal Analgesics Sales Value, 2020-2031 5.8.2 Middle East & Africa Transdermal Analgesics Sales Value by Country (%), 2024 VS 2031 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Transdermal Analgesics Sales Value Growth Trends, 2020 VS 2024 VS 2031 6.2 Key Countries/Regions Transdermal Analgesics Sales Value 6.2.1 Key Countries/Regions Transdermal Analgesics Sales Value, 2020-2031 6.2.2 Key Countries/Regions Transdermal Analgesics Sales Volume, 2020-2031 6.3 United States 6.3.1 United States Transdermal Analgesics Sales Value, 2020-2031 6.3.2 United States Transdermal Analgesics Sales Value by Type (%), 2024 VS 2031 6.3.3 United States Transdermal Analgesics Sales Value by Application, 2024 VS 2031 6.4 Europe 6.4.1 Europe Transdermal Analgesics Sales Value, 2020-2031 6.4.2 Europe Transdermal Analgesics Sales Value by Type (%), 2024 VS 2031 6.4.3 Europe Transdermal Analgesics Sales Value by Application, 2024 VS 2031 6.5 China 6.5.1 China Transdermal Analgesics Sales Value, 2020-2031 6.5.2 China Transdermal Analgesics Sales Value by Type (%), 2024 VS 2031 6.5.3 China Transdermal Analgesics Sales Value by Application, 2024 VS 2031 6.6 Japan 6.6.1 Japan Transdermal Analgesics Sales Value, 2020-2031 6.6.2 Japan Transdermal Analgesics Sales Value by Type (%), 2024 VS 2031 6.6.3 Japan Transdermal Analgesics Sales Value by Application, 2024 VS 2031 6.7 South Korea 6.7.1 South Korea Transdermal Analgesics Sales Value, 2020-2031 6.7.2 South Korea Transdermal Analgesics Sales Value by Type (%), 2024 VS 2031 6.7.3 South Korea Transdermal Analgesics Sales Value by Application, 2024 VS 2031 6.8 Southeast Asia 6.8.1 Southeast Asia Transdermal Analgesics Sales Value, 2020-2031 6.8.2 Southeast Asia Transdermal Analgesics Sales Value by Type (%), 2024 VS 2031 6.8.3 Southeast Asia Transdermal Analgesics Sales Value by Application, 2024 VS 2031 6.9 India 6.9.1 India Transdermal Analgesics Sales Value, 2020-2031 6.9.2 India Transdermal Analgesics Sales Value by Type (%), 2024 VS 2031 6.9.3 India Transdermal Analgesics Sales Value by Application, 2024 VS 2031 7 Company Profiles 7.1 Abbott Laboratories 7.1.1 Abbott Laboratories Company Information 7.1.2 Abbott Laboratories Introduction and Business Overview 7.1.3 Abbott Laboratories Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2025) 7.1.4 Abbott Laboratories Transdermal Analgesics Product Offerings 7.1.5 Abbott Laboratories Recent Development 7.2 AbbVie Inc. 7.2.1 AbbVie Inc. Company Information 7.2.2 AbbVie Inc. Introduction and Business Overview 7.2.3 AbbVie Inc. Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2025) 7.2.4 AbbVie Inc. Transdermal Analgesics Product Offerings 7.2.5 AbbVie Inc. Recent Development 7.3 Bayer AG 7.3.1 Bayer AG Company Information 7.3.2 Bayer AG Introduction and Business Overview 7.3.3 Bayer AG Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2025) 7.3.4 Bayer AG Transdermal Analgesics Product Offerings 7.3.5 Bayer AG Recent Development 7.4 Eli Lilly and Company 7.4.1 Eli Lilly and Company Company Information 7.4.2 Eli Lilly and Company Introduction and Business Overview 7.4.3 Eli Lilly and Company Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2025) 7.4.4 Eli Lilly and Company Transdermal Analgesics Product Offerings 7.4.5 Eli Lilly and Company Recent Development 7.5 endo pharmaceuticals, Glaxosmithkline plc 7.5.1 endo pharmaceuticals, Glaxosmithkline plc Company Information 7.5.2 endo pharmaceuticals, Glaxosmithkline plc Introduction and Business Overview 7.5.3 endo pharmaceuticals, Glaxosmithkline plc Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2025) 7.5.4 endo pharmaceuticals, Glaxosmithkline plc Transdermal Analgesics Product Offerings 7.5.5 endo pharmaceuticals, Glaxosmithkline plc Recent Development 7.6 johnson and johnson md&d 7.6.1 johnson and johnson md&d Company Information 7.6.2 johnson and johnson md&d Introduction and Business Overview 7.6.3 johnson and johnson md&d Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2025) 7.6.4 johnson and johnson md&d Transdermal Analgesics Product Offerings 7.6.5 johnson and johnson md&d Recent Development 7.7 Pfizer, Inc. 7.7.1 Pfizer, Inc. Company Information 7.7.2 Pfizer, Inc. Introduction and Business Overview 7.7.3 Pfizer, Inc. Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2025) 7.7.4 Pfizer, Inc. Transdermal Analgesics Product Offerings 7.7.5 Pfizer, Inc. Recent Development 7.8 Reckitt Benckiser Group 7.8.1 Reckitt Benckiser Group Company Information 7.8.2 Reckitt Benckiser Group Introduction and Business Overview 7.8.3 Reckitt Benckiser Group Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2025) 7.8.4 Reckitt Benckiser Group Transdermal Analgesics Product Offerings 7.8.5 Reckitt Benckiser Group Recent Development 7.9 Sanofi 7.9.1 Sanofi Company Information 7.9.2 Sanofi Introduction and Business Overview 7.9.3 Sanofi Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2025) 7.9.4 Sanofi Transdermal Analgesics Product Offerings 7.9.5 Sanofi Recent Development 8 Industry Chain Analysis 8.1 Transdermal Analgesics Industrial Chain 8.2 Transdermal Analgesics Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Transdermal Analgesics Sales Model 8.5.2 Sales Channel 8.5.3 Transdermal Analgesics Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.1.1 Research Programs/Design 10.1.1.2 Market Size Estimation 10.1.1.3 Market Breakdown and Data Triangulation 10.1.2 Data Source 10.1.2.1 Secondary Sources 10.1.2.2 Primary Sources 10.2 Author Details 10.3 Disclaimer
SummaryThe global market for Transdermal Analgesics was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031. Table of Contents1 Market Overview1.1 Transdermal Analgesics Product Introduction 1.2 Global Transdermal Analgesics Market Size Forecast 1.2.1 Global Transdermal Analgesics Sales Value (2020-2031) 1.2.2 Global Transdermal Analgesics Sales Volume (2020-2031) 1.2.3 Global Transdermal Analgesics Sales Price (2020-2031) 1.3 Transdermal Analgesics Market Trends & Drivers 1.3.1 Transdermal Analgesics Industry Trends 1.3.2 Transdermal Analgesics Market Drivers & Opportunity 1.3.3 Transdermal Analgesics Market Challenges 1.3.4 Transdermal Analgesics Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Transdermal Analgesics Players Revenue Ranking (2024) 2.2 Global Transdermal Analgesics Revenue by Company (2020-2025) 2.3 Global Transdermal Analgesics Players Sales Volume Ranking (2024) 2.4 Global Transdermal Analgesics Sales Volume by Company Players (2020-2025) 2.5 Global Transdermal Analgesics Average Price by Company (2020-2025) 2.6 Key Manufacturers Transdermal Analgesics Manufacturing Base and Headquarters 2.7 Key Manufacturers Transdermal Analgesics Product Offered 2.8 Key Manufacturers Time to Begin Mass Production of Transdermal Analgesics 2.9 Transdermal Analgesics Market Competitive Analysis 2.9.1 Transdermal Analgesics Market Concentration Rate (2020-2025) 2.9.2 Global 5 and 10 Largest Manufacturers by Transdermal Analgesics Revenue in 2024 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Analgesics as of 2024) 2.10 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Non opioids 3.1.2 Opioids 3.2 Global Transdermal Analgesics Sales Value by Type 3.2.1 Global Transdermal Analgesics Sales Value by Type (2020 VS 2024 VS 2031) 3.2.2 Global Transdermal Analgesics Sales Value, by Type (2020-2031) 3.2.3 Global Transdermal Analgesics Sales Value, by Type (%) (2020-2031) 3.3 Global Transdermal Analgesics Sales Volume by Type 3.3.1 Global Transdermal Analgesics Sales Volume by Type (2020 VS 2024 VS 2031) 3.3.2 Global Transdermal Analgesics Sales Volume, by Type (2020-2031) 3.3.3 Global Transdermal Analgesics Sales Volume, by Type (%) (2020-2031) 3.4 Global Transdermal Analgesics Average Price by Type (2020-2031) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Hospital 4.1.2 Pharmacy 4.1.3 Family 4.2 Global Transdermal Analgesics Sales Value by Application 4.2.1 Global Transdermal Analgesics Sales Value by Application (2020 VS 2024 VS 2031) 4.2.2 Global Transdermal Analgesics Sales Value, by Application (2020-2031) 4.2.3 Global Transdermal Analgesics Sales Value, by Application (%) (2020-2031) 4.3 Global Transdermal Analgesics Sales Volume by Application 4.3.1 Global Transdermal Analgesics Sales Volume by Application (2020 VS 2024 VS 2031) 4.3.2 Global Transdermal Analgesics Sales Volume, by Application (2020-2031) 4.3.3 Global Transdermal Analgesics Sales Volume, by Application (%) (2020-2031) 4.4 Global Transdermal Analgesics Average Price by Application (2020-2031) 5 Segmentation by Region 5.1 Global Transdermal Analgesics Sales Value by Region 5.1.1 Global Transdermal Analgesics Sales Value by Region: 2020 VS 2024 VS 2031 5.1.2 Global Transdermal Analgesics Sales Value by Region (2020-2025) 5.1.3 Global Transdermal Analgesics Sales Value by Region (2026-2031) 5.1.4 Global Transdermal Analgesics Sales Value by Region (%), (2020-2031) 5.2 Global Transdermal Analgesics Sales Volume by Region 5.2.1 Global Transdermal Analgesics Sales Volume by Region: 2020 VS 2024 VS 2031 5.2.2 Global Transdermal Analgesics Sales Volume by Region (2020-2025) 5.2.3 Global Transdermal Analgesics Sales Volume by Region (2026-2031) 5.2.4 Global Transdermal Analgesics Sales Volume by Region (%), (2020-2031) 5.3 Global Transdermal Analgesics Average Price by Region (2020-2031) 5.4 North America 5.4.1 North America Transdermal Analgesics Sales Value, 2020-2031 5.4.2 North America Transdermal Analgesics Sales Value by Country (%), 2024 VS 2031 5.5 Europe 5.5.1 Europe Transdermal Analgesics Sales Value, 2020-2031 5.5.2 Europe Transdermal Analgesics Sales Value by Country (%), 2024 VS 2031 5.6 Asia Pacific 5.6.1 Asia Pacific Transdermal Analgesics Sales Value, 2020-2031 5.6.2 Asia Pacific Transdermal Analgesics Sales Value by Region (%), 2024 VS 2031 5.7 South America 5.7.1 South America Transdermal Analgesics Sales Value, 2020-2031 5.7.2 South America Transdermal Analgesics Sales Value by Country (%), 2024 VS 2031 5.8 Middle East & Africa 5.8.1 Middle East & Africa Transdermal Analgesics Sales Value, 2020-2031 5.8.2 Middle East & Africa Transdermal Analgesics Sales Value by Country (%), 2024 VS 2031 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Transdermal Analgesics Sales Value Growth Trends, 2020 VS 2024 VS 2031 6.2 Key Countries/Regions Transdermal Analgesics Sales Value 6.2.1 Key Countries/Regions Transdermal Analgesics Sales Value, 2020-2031 6.2.2 Key Countries/Regions Transdermal Analgesics Sales Volume, 2020-2031 6.3 United States 6.3.1 United States Transdermal Analgesics Sales Value, 2020-2031 6.3.2 United States Transdermal Analgesics Sales Value by Type (%), 2024 VS 2031 6.3.3 United States Transdermal Analgesics Sales Value by Application, 2024 VS 2031 6.4 Europe 6.4.1 Europe Transdermal Analgesics Sales Value, 2020-2031 6.4.2 Europe Transdermal Analgesics Sales Value by Type (%), 2024 VS 2031 6.4.3 Europe Transdermal Analgesics Sales Value by Application, 2024 VS 2031 6.5 China 6.5.1 China Transdermal Analgesics Sales Value, 2020-2031 6.5.2 China Transdermal Analgesics Sales Value by Type (%), 2024 VS 2031 6.5.3 China Transdermal Analgesics Sales Value by Application, 2024 VS 2031 6.6 Japan 6.6.1 Japan Transdermal Analgesics Sales Value, 2020-2031 6.6.2 Japan Transdermal Analgesics Sales Value by Type (%), 2024 VS 2031 6.6.3 Japan Transdermal Analgesics Sales Value by Application, 2024 VS 2031 6.7 South Korea 6.7.1 South Korea Transdermal Analgesics Sales Value, 2020-2031 6.7.2 South Korea Transdermal Analgesics Sales Value by Type (%), 2024 VS 2031 6.7.3 South Korea Transdermal Analgesics Sales Value by Application, 2024 VS 2031 6.8 Southeast Asia 6.8.1 Southeast Asia Transdermal Analgesics Sales Value, 2020-2031 6.8.2 Southeast Asia Transdermal Analgesics Sales Value by Type (%), 2024 VS 2031 6.8.3 Southeast Asia Transdermal Analgesics Sales Value by Application, 2024 VS 2031 6.9 India 6.9.1 India Transdermal Analgesics Sales Value, 2020-2031 6.9.2 India Transdermal Analgesics Sales Value by Type (%), 2024 VS 2031 6.9.3 India Transdermal Analgesics Sales Value by Application, 2024 VS 2031 7 Company Profiles 7.1 Abbott Laboratories 7.1.1 Abbott Laboratories Company Information 7.1.2 Abbott Laboratories Introduction and Business Overview 7.1.3 Abbott Laboratories Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2025) 7.1.4 Abbott Laboratories Transdermal Analgesics Product Offerings 7.1.5 Abbott Laboratories Recent Development 7.2 AbbVie Inc. 7.2.1 AbbVie Inc. Company Information 7.2.2 AbbVie Inc. Introduction and Business Overview 7.2.3 AbbVie Inc. Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2025) 7.2.4 AbbVie Inc. Transdermal Analgesics Product Offerings 7.2.5 AbbVie Inc. Recent Development 7.3 Bayer AG 7.3.1 Bayer AG Company Information 7.3.2 Bayer AG Introduction and Business Overview 7.3.3 Bayer AG Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2025) 7.3.4 Bayer AG Transdermal Analgesics Product Offerings 7.3.5 Bayer AG Recent Development 7.4 Eli Lilly and Company 7.4.1 Eli Lilly and Company Company Information 7.4.2 Eli Lilly and Company Introduction and Business Overview 7.4.3 Eli Lilly and Company Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2025) 7.4.4 Eli Lilly and Company Transdermal Analgesics Product Offerings 7.4.5 Eli Lilly and Company Recent Development 7.5 endo pharmaceuticals, Glaxosmithkline plc 7.5.1 endo pharmaceuticals, Glaxosmithkline plc Company Information 7.5.2 endo pharmaceuticals, Glaxosmithkline plc Introduction and Business Overview 7.5.3 endo pharmaceuticals, Glaxosmithkline plc Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2025) 7.5.4 endo pharmaceuticals, Glaxosmithkline plc Transdermal Analgesics Product Offerings 7.5.5 endo pharmaceuticals, Glaxosmithkline plc Recent Development 7.6 johnson and johnson md&d 7.6.1 johnson and johnson md&d Company Information 7.6.2 johnson and johnson md&d Introduction and Business Overview 7.6.3 johnson and johnson md&d Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2025) 7.6.4 johnson and johnson md&d Transdermal Analgesics Product Offerings 7.6.5 johnson and johnson md&d Recent Development 7.7 Pfizer, Inc. 7.7.1 Pfizer, Inc. Company Information 7.7.2 Pfizer, Inc. Introduction and Business Overview 7.7.3 Pfizer, Inc. Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2025) 7.7.4 Pfizer, Inc. Transdermal Analgesics Product Offerings 7.7.5 Pfizer, Inc. Recent Development 7.8 Reckitt Benckiser Group 7.8.1 Reckitt Benckiser Group Company Information 7.8.2 Reckitt Benckiser Group Introduction and Business Overview 7.8.3 Reckitt Benckiser Group Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2025) 7.8.4 Reckitt Benckiser Group Transdermal Analgesics Product Offerings 7.8.5 Reckitt Benckiser Group Recent Development 7.9 Sanofi 7.9.1 Sanofi Company Information 7.9.2 Sanofi Introduction and Business Overview 7.9.3 Sanofi Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2025) 7.9.4 Sanofi Transdermal Analgesics Product Offerings 7.9.5 Sanofi Recent Development 8 Industry Chain Analysis 8.1 Transdermal Analgesics Industrial Chain 8.2 Transdermal Analgesics Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Transdermal Analgesics Sales Model 8.5.2 Sales Channel 8.5.3 Transdermal Analgesics Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.1.1 Research Programs/Design 10.1.1.2 Market Size Estimation 10.1.1.3 Market Breakdown and Data Triangulation 10.1.2 Data Source 10.1.2.1 Secondary Sources 10.1.2.2 Primary Sources 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療/ヘルスケア)の最新刊レポート
QYResearch社の医薬・ヘルスケア分野での最新刊レポート
本レポートと同じKEY WORD(demand)の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|